Page last updated: 2024-11-06

mitomycin and Tuberculosis, Drug-Resistant

mitomycin has been researched along with Tuberculosis, Drug-Resistant in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karale, UB1
Krishna, VS1
Krishna, EV1
Choudhari, AS1
Shukla, M1
Gaikwad, VR1
Mahizhaveni, B1
Chopra, S1
Misra, S1
Sarkar, D1
Sriram, D1
Dusthackeer, VNA1
Rode, HB1

Other Studies

1 other study available for mitomycin and Tuberculosis, Drug-Resistant

ArticleYear
Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
    European journal of medicinal chemistry, 2019, Sep-15, Volume: 178

    Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecu

2019